Literature DB >> 2173924

HSV-1 vector mediated neuronal gene delivery. Strategies for molecular neuroscience and neurology.

A Freese1, A I Geller, R Neve.   

Abstract

Entities:  

Mesh:

Year:  1990        PMID: 2173924     DOI: 10.1016/0006-2952(90)90711-s

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  11 in total

1.  Characterization of promoter function and cell-type-specific expression from viral vectors in the nervous system.

Authors:  R L Smith; D L Traul; J Schaack; G H Clayton; K J Staley; C L Wilcox
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Correction of a rat model of Parkinson's disease by coexpression of tyrosine hydroxylase and aromatic amino acid decarboxylase from a helper virus-free herpes simplex virus type 1 vector.

Authors:  Mei Sun; Guo-Rong Zhang; Lingxin Kong; Courtney Holmes; Xiaodan Wang; Wei Zhang; David S Goldstein; Alfred I Geller
Journal:  Hum Gene Ther       Date:  2003-03-20       Impact factor: 5.695

Review 3.  Molecular analysis of the function of the neuronal growth-associated protein GAP-43 by genetic intervention.

Authors:  R L Neve; K J Ivins; L I Benowitz; M J During; A I Geller
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

Review 4.  Physiological relevance and functional potential of central nervous system-derived cell lines.

Authors:  S R Whittemore; E Y Snyder
Journal:  Mol Neurobiol       Date:  1996-02       Impact factor: 5.590

5.  Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy.

Authors:  A Freese; A Geller
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

6.  Gene transfer by viral vectors for gene therapy.

Authors:  Y Becker; G Darai
Journal:  J Mol Med (Berl)       Date:  1995-03       Impact factor: 4.599

Review 7.  Herpes simplex virus vectors for gene therapy.

Authors:  D S Latchman
Journal:  Mol Biotechnol       Date:  1994-10       Impact factor: 2.695

8.  Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.

Authors:  Mei Sun; Lingxin Kong; Xiaodan Wang; Courtney Holmes; Qingsheng Gao; Guo-Rong Zhang; Josef Pfeilschifter; David S Goldstein; Alfred I Geller
Journal:  Hum Gene Ther       Date:  2004-12       Impact factor: 5.695

Review 9.  Gene therapy for PNET.

Authors:  C Raffel
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

10.  An HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells.

Authors:  A I Geller; M J During; Y J Oh; A Freese; K O'Malley
Journal:  J Neurochem       Date:  1995-02       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.